Combination use of ivabradine with sacubitril/valsartan a review of clinical effectiveness and guidelines
The objective of this report is to provide a summary of the evidence of clinical effectiveness and clinical practice guidelines regarding the combination of ivabradine and sacubitril/valsartan for the treatment of heart failure
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, February 13, 2020
|
Edition: | Version: 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references